PL02.04 Phase 3 Study of Ivonescimab (AK112) vs. Pembrolizumab as First-line Treatment for PD-L1-positive Advanced NSCLC: Primary Analysis of HARMONi-2
2024 · Journal of Thoracic Oncology · 22 citations
https://doi.org/10.1016/j.jtho.2024.09.012
M
Min Zhou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
60
Papers
586
Citations
10
h-index
11
i10-index
Min Zhou is an academic researcher from Nanjing University of Chinese Medicine. The author has contributed to research in topics: COVID-19 Clinical Research Studies & SARS-CoV-2 and COVID-19 Research & Mitochondrial Function and Pathology. The author has an h-index of 10, co-authored 51 publications.
ORCID: 0000-0003-1838-9010Papers by this author
worksRutin ameliorates stress–induced blood‒brain barrier dysfunction and cognitive decline via the endothelial HDAC1‒Claudin–5 axis
2025 · Fluids and Barriers of the CNS · 12 citations
https://doi.org/10.1186/s12987-025-00639-8
High-intensity interval training improves cognitive dysfunction in chronically stressed mice through alleviating homocysteine-induced transcriptional repression of Cldn5
2025 · Neurobiology of Stress · 1 citations
https://doi.org/10.1016/j.ynstr.2025.100758
Integrative analysis revealed the effect of gut microbiota and metabolites on growth performance of Ningdu hybrid chicken
2025 · Poultry Science · 0 citations
https://doi.org/10.1016/j.psj.2025.105891
Prognostic analysis of fenestrated-branched endovascular aortic repair with physician-modified endografts for repair of complex abdominal and thoracoabdominal aortic aneurysms: a case control study
2025 · International Journal of Surgery · 0 citations
https://doi.org/10.1097/js9.0000000000003935
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat